Research News

Dr. Chiaramello
GW Researchers Launch the First Basket Phase I Clinical Trial on Two Ultra-Rare Mitochondrial Diseases
Anne Chiaramello, PhD, founding director the Mito-EpiGen Program at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) received FDA approval for the first basket clinical trial in the US for two ultra-rare inherited mitochondrial diseases, MELAS and LHON-Plus. 
Subscribe to Research News